Xanax is being recalled in the U.S. over possible contaminant
Mylan Pharmaceuticals has issued a nationwide recall of a single batch of alprazolam 0.5 mg (the generic version of Xanax), which comes in 500-count bottles and has the lot number 8082708, according to the FDA.
The medication was distributed in the U.S. between July and August 2019, and has an expiration date of September 2020.
According to an FDA statement on the Xanax recall, the risk of becoming ill from the contaminated medication is unlikely. “Clinical impact from the foreign material, if present, is expected to be rare,” the statement said, “but the remote risk of infection to a patient cannot be ruled out. To date, Mylan has not received any adverse events related to this batch.”
If your medication is part of the batch being recalled, do not continue to take it. Instead, Mylan recommends contacting Stericycle, a medical waste disposal company, at 1-888-843-0255, which will provide the documentation packet to return the product to Stericycle.
